Apelin Is a Prototype of Novel Drugs for the Treatment of Acute Myocardial Infarction and Adverse Myocardial Remodeling

In-hospital mortality in patients with ST-segment elevation myocardial infarction (STEMI) is 5–6%. Consequently, it is necessary to develop fundamentally novel drugs capable of reducing mortality in patients with acute myocardial infarction. Apelins could be the prototype for such drugs. Chronic adm...

Descripción completa

Detalles Bibliográficos
Autores principales: Popov, Sergey V., Maslov, Leonid N., Mukhomedzyanov, Alexandr V., Kurbatov, Boris K., Gorbunov, Alexandr S., Kilin, Michail, Azev, Viacheslav N., Khlestkina, Maria S., Sufianova, Galina Z.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10056827/
https://www.ncbi.nlm.nih.gov/pubmed/36986889
http://dx.doi.org/10.3390/pharmaceutics15031029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10056827/
https://www.ncbi.nlm.nih.gov/pubmed/36986889
http://dx.doi.org/10.3390/pharmaceutics15031029

Ejemplares similares